{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-24-000006","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2024-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.650469+00:00","generated_at":"2026-06-05T03:09:45.635166+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kewaunee Q3 FY2024 EPS $0.85 vs $0.25 YoY; net income triples despite 23% sales drop","bullets":["Sales $46.8M, down 23% YoY from $60.8M; net income $2.5M vs $0.7M.","Diluted EPS $0.85 (prior year $0.25); EBITDA $4.4M vs $2.7M.","Domestic segment net income rose to $2.6M from $0.4M on improved productivity.","International sales fell 39% to $15.0M due to two large non-recurring projects.","Cash on hand $27.1M, up from $13.8M at April 2023; debt-to-equity improved to 0.87."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-24-000006","json":"https://secwatch.observer/filing/0000055529-24-000006.json","markdown":"https://secwatch.observer/filing/0000055529-24-000006.md","text":"https://secwatch.observer/filing/0000055529-24-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552924000006/0000055529-24-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552924000006/kequ-20240306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T03:09:45.635166+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07d6d685736f15044495bc50a5a31b88e00d6beb","claim":"KEWAUNEE SCIENTIFIC CORP /DE/ reported third quarter ended January 31, 2024 results: revenue $46,778,000, net income $2,521,000, EPS $0.85.","evidence_excerpt":"Sales during the third quarter of fiscal year 2024 were $46,778,000, a decrease of 23.1% compared to sales of $60,821,000 from the prior year's third quarter. Pre-tax earnings for the quarter were $3,515,000 compared to $2,060,000 for the prior year quarter, an increase of 70.6%. Net earnings were $2,521,000 compared to net earnings of $723,000 for the prior year quarter. EBITDA 1 for the quarter was $4,414,000 compared to $2,683,000 for the prior year quarter. Diluted earnings per share was $0.85 compared to diluted earnings per share of $0.25 in the prior year quarter.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/55529/000005552924000006/0000055529-24-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended January 31, 2024"},{"label":"Revenue","value":"$46,778,000"},{"label":"Net income","value":"$2,521,000"},{"label":"EPS","value":"$0.85"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}